VGRLX yields 4.87% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, VGRLX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VGRLX + MRK for your $10,000?
This fund invests in international real estate stocks including real estate investment trusts—companies that own office buildings, hotels, and other real estate. REITs often perform differently from other stocks and bonds, so this fund may add diversification to a portfolio already made up of stocks and bonds. A key risk is the fund’s narrow scope; since it invests solely within the real estate industry, it may be more volatile than more broadly diversified stock funds. Because it invests in non-U.S. stocks, including those in developed and emerging markets, the fund can be subject to risks unique to international investing, such as currency risk. Investors may wish to consider this fund as a complement to an already diversified stock portfolio.
Full VGRLX Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.